Quick answer: The HbA1c test measures the percentage of your red blood cell hemoglobin chemically bonded to glucose (glycated). Because human red blood cells circulate for approximately 120 days, HbA1c reflects your weighted average blood glucose over the past 2 to 3 months, with the most recent 30 days contributing about 50% of the result:
- Normal / Healthy: Below 5.7% (Estimated Average Glucose < 117 mg/dL)
- Prediabetes (Impaired Glucose Regulation): 5.7% to 6.4% (eAG 117–137 mg/dL)
- Diabetes Mellitus: 6.5% or higher on two separate occasions (eAG ≥ 140 mg/dL)
- Diabetic Target: Most non-pregnant adults with diabetes target an HbA1c under 7.0% to prevent microvascular complications (retinopathy, nephropathy, neuropathy). [1–3]
Medically reviewed by: Dr. Shantakumar Muruda, MD (Biochemistry), Founder & CEO, QXL Diagnostics Central Reference Laboratory, Bengaluru.
Published: 18 November 2026 · Reading time: approximately 13 minutes.
Accreditation: NABL Accredited (MC-6849) under ISO 15189:2022.
HbA1c to Estimated Average Glucose (eAG) Conversion Table#
Patients are often confused because their glucometers display blood sugar in milligrams per deciliter (mg/dL), while lab reports show HbA1c as a percentage (%). The American Diabetes Association (ADA) establishes the mathematical relationship: eAG (mg/dL) = 28.7 × HbA1c - 46.7.
| HbA1c Level (%) | Estimated Average Glucose (eAG in mg/dL) | Clinical Category | Recommended Action |
|---|---|---|---|
| 5.0% | 97 mg/dL | Optimal Normal | Routine annual wellness screening |
| 5.5% | 111 mg/dL | Normal | Healthy diet, active lifestyle |
| 5.7% | 117 mg/dL | Prediabetes Threshold | Baseline lifestyle and dietary intervention |
| 6.0% | 126 mg/dL | Moderate Prediabetes | Insulin resistance audit (HOMA-IR), carbohydrate restriction |
| 6.4% | 137 mg/dL | High-Risk Prediabetes | Intensive metabolic intervention; annual cardiovascular risk screen |
| 6.5% | 140 mg/dL | Diabetes Diagnostic Cutoff | Clinical confirmation; consultation with physician/diabetologist |
| 7.0% | 154 mg/dL | Standard Diabetic Treatment Target | Acceptable control for most adults with diagnosed diabetes |
| 8.0% | 183 mg/dL | Sub-optimal Diabetic Control | Medication titration; dietary adherence review |
| 9.0% | 212 mg/dL | High Vascular Risk | Nephropathy/retinopathy screening; intensive clinical therapy |
| 10.0% | 240 mg/dL | Very High Risk | Immediate specialist intervention to prevent acute complications |
Why HPLC is the Gold Standard for HbA1c Testing#
Not all laboratory instruments measure HbA1c with the same clinical precision. Cheap point-of-care (POC) fingerstick cartridges often suffer from significant calibration drift and cross-reactivity.
At QXL Diagnostics Central Reference Laboratory in Kengeri, Bengaluru, HbA1c is analyzed exclusively using Automated High-Performance Liquid Chromatography (HPLC) with Ion-Exchange Separation:
- NGSP & IFCC Standardized: Traceable directly to the National Glycohemoglobin Standardization Program and the International Federation of Clinical Chemistry.
- Hemoglobin Variant Detection: Ion-exchange HPLC generates an automated chromatographic peak profile that immediately alerts our clinical biochemists to the presence of abnormal hemoglobin variants (such as HbS, HbE, HbD-Punjab, or elevated HbF), which falsely distort immunoassay readings.
- Analytical Precision: Runs with an intra-assay Coefficient of Variation (CV) < 2.0%, far exceeding international quality benchmarks.
Factors That Can Skew HbA1c Results#
Because HbA1c relies on red blood cell survival, any medical condition that alters erythrocyte lifespan will impact the report:
- Falsely Lowered HbA1c: Hemolytic anemia, recent acute blood loss, blood transfusion within the last 60 days, chronic kidney disease on erythropoietin therapy, or chronic liver disease.
- Falsely Elevated HbA1c: Severe Iron Deficiency Anemia (where older, more glycated red blood cells remain in circulation longer), Vitamin B12 or Folate deficiency, severe hypertriglyceridemia, or alcoholism.
When HbA1c is clinically discordant with daily capillary glucose levels, our biochemists recommend measuring Serum Fructosamine or Glycated Albumin, which provide a 2-to-3-week glycemic window independent of hemoglobin kinetics.
How Often Should You Check Your HbA1c?#
- Healthy Individuals (< 5.7%): Once every 1 to 2 years as part of a routine Quick Fit Checkup.
- Individuals with Prediabetes (5.7–6.4%): Every 6 months to track the effectiveness of weight loss, low-glycemic diets, and exercise.
- Stable Diabetics Meeting Goals (< 7.0%): Every 6 months.
- Uncontrolled Diabetics or Patients with Recent Medication Changes: Every 3 months (quarterly), allowing the physician to evaluate therapeutic efficacy before long-term organ damage occurs.
Book your doctor-led HbA1c Blood Test in Bangalore (₹380, no fasting required) with same-day digital reports and free doorstep sample collection.
Frequently Asked Questions (FAQs)#
1. Does fasting affect my HbA1c test result?#
No. Fasting has zero effect on HbA1c. You can eat and drink normally before the blood draw. However, if your doctor orders a Fasting Blood Glucose (FBS) or Lipid Profile on the same sample, you must observe an 8-to-10-hour overnight fast.
2. Can I bring my HbA1c down in a week?#
No. Because HbA1c measures red blood cells that have been circulating for up to 120 days, it changes gradually. Significant dietary improvements or new medications will begin reflecting in the HbA1c reading after 4 to 6 weeks, with full equilibration taking approximately 3 months.
3. What is the difference between daily fingerstick sugar and HbA1c?#
Daily capillary fingerstick testing shows your glucose level at that exact minute, which fluctuates wildly after meals, exercise, and stress. HbA1c shows the cumulative biological exposure over months, eliminating day-to-day fluctuations.
References & Clinical Guidelines#
- American Diabetes Association (ADA). Standards of Care in Diabetes—2026. Diabetes Care 2026;49(Suppl. 1):S1–S290.
- National Glycohemoglobin Standardization Program (NGSP). Harmonizing HbA1c Testing Worldwide. 2025.
- World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Geneva: WHO; 2021.
- ISO 15189:2022. Medical laboratories — Requirements for quality and competence. International Organization for Standardization.
Medical & Laboratory Disclaimer
This clinical article is published solely for patient education and informational purposes. It does not replace personal medical advice, clinical diagnosis, prenatal genetic counselling, or obstetric supervision. Appropriate laboratory investigations must be determined by your treating physician based on your personal health history.
Dr. Shantakumar Muruda, MD (Biochemistry), PHFI Diabetologist
Head of Clinical Biochemistry & Quality Management, QXL Diagnostics Bengaluru (NABL Accredited Laboratory MC-6849). Trained Lead Assessor for ISO 15189:2022 medical laboratory standards.
QXL Clinical Editorial Commitment: Every health guide, biomarker explanation, and screening schedule published on this portal undergoes rigorous clinical review by qualified MD pathologists and biochemists to ensure adherence to peer-reviewed evidence (ACOG, WHO, ICMR) and laboratory diagnostic accuracy.



